Podcast on Clinical Trial Challenges and FDA Solutions

November 5, 2021

A recent episode of the Business of Biotech podcast series features Allan Shaw. This installment highlights some of the major problems arising from clinical trials, along with possible solutions.

“The clinical trials status quo is a roadblock. They’re slow, they’re inefficient, and they’re expensive. On this episode of the Business of Biotech, friend and frequent guest Allan Shaw shares some strong opinions on what’s wrong with clinical trials, and what the industry (read: you) and the FDA need to do to make them right.” Listen to the podcast here.

(Source: Bioprocess Online, 10/18/21)

Share This Story!